Jacobs Levy Equity Management, Inc Care Dx, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 814,716 shares of CDNA stock, worth $17.6 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
814,716
Previous 1,178,040
30.84%
Holding current value
$17.6 Million
Previous $18.3 Million
39.03%
% of portfolio
0.1%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding CDNA
# of Institutions
216Shares Held
50.9MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$97.8 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$67.8 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$64.4 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$43.9 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.15B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...